Researchers used PET scans and blood psilocin levels to verify that the subjective experiences brought on by psilocybin come from stimulation of the serotonin 5-HT2A receptor.
Magic mushrooms may be synthesizing this newly-discovered compound from baeocystin.
Binding affinity studies show psilocin and psilocybin have different preferences for serotonin receptors.
You may have heard of magic mushrooms or even consumed them. But what are they?
Psilocybin produces more insightful and mystical experiences, but dextromethorphan causes greater feelings of disembodiment.
Data analysis and gene expression maps confirm the role of the 5-HT2A receptor in the effects of LSD.
Researchers push to move psilocybin from Schedule I to Schedule IV if Phase III clinical trials are successful.
Psilocin makes neurons grow faster and produce more connections.
A study in the mouse brain shows serotonin neurons are organized into parallel subsystems.
St Vincent's Hospital of Melbourne, Australia will begin treating patients in April
Psychedelic Science Review is embarking on a journey to bring cutting edge science in the field of psychedelics to you in the most accessible, thorough and scientifically accurate way possible.
But we still have a long way to go...
Please bear with us as we roll out the our brand new site, and check back frequently for updates. Support free access to the latest psychedelic science by liking our Facebook page and by following @psyscireview on Twitter.
